VLLASALIU D, SHUBBER S, GARNETT M, ALEXANDER C, EATON M and STOLNIK S, 2012. Evaluation Of Calcium Depletion As A Strategy For Enhancement Of Mucosal Absorption Of Macromolecules. Biochemical And Biophysical Research Communications. 418(1), 128-33 MORADI E, VLLASALIU D, GARNETT M, FALCONE F and STOLNIK S, 2012. Ligand density and clustering effects on endocytosis of folate modified nanoparticles. RSC Advances. (In Press.)
BUTTLE, D.J., BEHNKE, J.M., BARTLEY, Y., ELSHEIKHA, H.M., BARTLEY, D.J., GARNETT, M., DONNAN, A.A., JACKSON, F., LOWE, A. and DUCE, I.R., 2011. Oral dosing with papaya latex is an effective anthelmintic treatment for sheep infected with Haemonchus contortus Parasites and Vectors. 4, 36 VLLASALIU D, FOWLER R, GARNETT M, EATON M and STOLNIK S, 2011. Barrier Characteristics Of Epithelial Cultures Modelling The Airway And Intestinal Mucosa: A Comparison. Biochemical And Biophysical Research Communications. 415(4), 579-85 CONROY, S., GARNETT, M., CRAVEN, I., VLOEBERGHS, M., GRUNDY, R. and WALKER, D., 2010. Medulloblastoma in childhood- revisiting intrathecal therapy in infants and children. Cancer Chemotherapy and Pharmacology. 65, 1173-1189 VLLASALIU, DRITON, EXPOSITO-HARRIS, RUTH, HERAS, ANGELES, CASETTARI, LUCA, GARNETT, MARTIN, ILLUM, LISBETH and STOLNIK, SNOW, 2010. Tight junction modulation by chitosan nanoparticles: comparison with chitosan solution. International journal of pharmaceutics. 400(1-2), 183-93 ABULATEEFEH, S.R., SAEED, A.O., AYLOTT, J.W., CHAN, W.C., GARNETT, M.C., SAUNDERS and ALEXANDER, C., 2009. Facile synthesis of responsive nanoparticles with reversible, tuneable and rapid thermal transitions from biocompatible constituents Chemical Communications. 40, 6068-6070 GARNETT, MC, FERRUTI, P, RANUCCI, E, SUARDI, MA, HEYDE, M and SLEAT, R, 2009. Sterically Stabilized Self-Assembling Reversibly Cross-Linked Polyelectrolyte Complexes With Nucleic Acids For Environmental And Medical Applications HOWDEN, L, GIDDINGS, D, POWER, H, AROUSSI, A, VLOEBERGHS, M, GARNETT, M and WALKER, D, 2008. Three-dimensional cerebrospinal fluid flow within the human ventricular system. Computer methods in biomechanics and biomedical engineering. 11(2), 123-33 ORAFI, H., KALLINTERI, P, GARNETT, M., HUGGINS, S., HUTCHEON, G. and POURCAIN, C., 2008. Novel poly (glycerol-adipate) polymers used for nanoparticle making: A study of surface free energy Iranian Journal of Pharmaceutical Research. 7(1), 11-19
PURI, S., KALLINTERI, P., HIGGINS, S., HUTCHEON, G. A. and GARNETT, M. C., 2008. Drug incorporation and release of water soluble drugs from novel functionalised poly(glycerol adipate) nanoparticles JOURNAL OF CONTROLLED RELEASE. VOL 125(NUMBER 1), 59-67 MENG, W., KALLINTERI, P., WALKER, D.A., PARKER, T.L. and GARNETT, M.C., 2007. Evaluation of poly(glycerol-adipate) nanoparticle uptake in an <i>in vitro</i> 3-D brain tumor co-culture model Experimental Biology and Medicine. 232(8), 1100-1108 HEYDE, MIEKE, PARTRIDGE, KRIS A., HOWDLE, STEVE M., OREFFO, RICHARD O.C., GARNETT, MARTIN C. and SHAKESHEFF, KEVIN M., 2007. Development of a controlled non-viral DNA release system from PDLLA scaffolds fabricated using a supercritical CO2 technique Biotechnology and Bioengineering. 98(3), 679 - 693 HEYDE, M, PARTRIDGE, K. A., OREFFO, R.O.C., HOWDLE, S. M., SHAKESHEFF, K.M. and GARNETT, M.C, 2007. Gene Therapy Used for Tissue Engineering Applications J Pharm Pharmacol.. 59(3), 329-350 KALLINTERI, P. AND GARNETT, M.C., 2007. Polymeric nanoparticles for drug delivery. In: KUMA, C., ed., Nanotechnologies for the life sciences 1st. 10 Nanomaterials for medical diagnosis and therapy. Wiley VCH. 409-470
GARNETT, M.C., 2007. Biodistribution of nanoparticles:insights from drug delivery. In: MONTEIRO-RIVIERE, N.A. and TRAN, C.L., eds., Nanotoxicology: Characterisation, dosing and health effects Informa Healthcare. (In Press.)
MENG, W., PARKER, T.L., KALLINTERI, P., WALKER, D.A., HIGGINS, S., HUTCHEON, G.A. and GARNETT, M.C.., 2006. Uptake and metabolism of novel biodegradable poly(glycerol-adipate) nanoparticles in DAOY monolayer Journal of Controlled Release. 116(3), 314-321 GARNETT, M.C., FERRUTI, P. and RANUCCI, E., 2006. Polymers Great Britain UK06-0051 10/01/2006 00:00:00 (In Press.)
GARNETT, M. C. and KALLINTERI, P., 2006. Nanomedicines and nanotoxicology: some physiological principles OCCUPATIONAL MEDICINE -OXFORD-. VOL 56(NUMB 5), 307-311 KALLINTERI, P., HIGGINS, S., HUTCHEON, G.A., ST POURÇAIN, C.B. and GARNETT, M.C., 2005. Novel functionalized biodegradable polymers for nanoparticle drug delivery systems Biomacromolecules. 6(4), 1885-1894 WALKER,D.A., AMMOURAH,S., AROUSSI,A., GARNETT,M.C., HOWDEN,L., POWER,H. and VLOEBERGHS,M.H, 2005. Physical and numerical modelling cerebrospinal fluid behaviour for drug delivery to the leptomeninges. In: 6th Meeting of the European Association for Neuro-Oncology..
STOLNIK, S., HEALD, C. R., GARNETT, M. G., ILLUM, L. and DAVIS, S. S., 2005. Differences in the adsorption behaviour of poly(ethylene oxide) copolymers onto model polystyrene nanoparticles assessed by isothermal titration microcalorimetry correspond to the biological differences Journal of Drug Targeting. VOL 13(ISSU 8/9), 449-458 WINTER, J. A., DAVIES, O. R., BROWN, A. P., GARNETT, M. C., STOLNIK, S. and PRITCHARD, D. I., 2005. The assessment of hookworm calreticulin as a potential vaccine for necatoriasis Parasite Immunology. VOL 27(NUMBER 4), 139-146 GARNETT,M.C., 2005. Nanomedicines: Delivering drugs using bottom up nanotechnology International Journal of Nanoscience. 4, 855-861 DESHPANDE, M.C., DAVIES, M.C., GARNETT, M.C., WILLIAMS, P.M., ARMITAGE, D., BAILEY, L., VAMVAKAKI, M., ARMES, S.P. and STOLNIK, S., 2004. The effect of poly(ethylene glycol) molecular architecture on cellular interaction and uptake of DNA complexes Journal of Controlled Release. 97(1), 143-156 HEALD, C.R., STOLNIK, S., DE MATTEIS, C., GARNETT, M.C., ILLUM, L., DAVIS, S.S. and LEERMAKERS, F.A.M., 2003. Characterisation of poly(lactic acid):poly(ethyleneoxide) (PLA:PEG) nanoparticles using the self-consistent theory modelling approach Colloids and Surfaces A: Physicochemical and Engineering Aspects. 212(1), 57-64 RUNGSARDTHONG,U., EHTEZAZI,T., BAILEY,L., ARMES,S.P., GARNETT,M.C. and STOLNIK-TRENKIC,S., 2003. Effect of polymer ionization on the interaction with DNA in non-viral gene delivery systems Biomacromolecules. 4(3), 683-690 RILEY, T., HEALD, C. R., STOLNIK, S., GARNETT, M. C., ILLUM, L., DAVIS, S. S., KING, S. M., HEENAN, R. K., PURKISS, S. C. and BARLOW, R. J., 2003. Core-Shell Structure of PLA-PEG Nanoparticles Used for Drug Delivery Langmuir. VOL 19(PART 20), 8428-8435 YONG,S.H., GARNETT,M.C., HOPPER,M., FRIER,M. and PERKINS,A.C, 2003. B55 and C595 anti-MUC1 monoclonal antibody as potential targeting agent for the treatment of superficial bladder cancer In: Cellular transport strategies for the targeting of epitopes, drugs and reporter molecules. 42
FRIER,M.C., YONG,S.C., PERKINS,A.C., GARNETT,M.C. and DAZA-RAMIREZ,P.C, 2003. Abstract: 99mTc radiolabelling of preformed liposomes: old technology, new method Nuclear Medicine Communications. 24(4), 446-7 FRIER,M., YONG,S.H., PERKINS,A.C., GARNETT,M. and DAZA-RAMIREZ,P., 2003. Biodistribution of radiolabelled liposomal doxorubicin in mice by scintigraphic imaging European Journal of Cancer Supplements. 1(5), S215-S216 Abstract 715 RACKSTRAW, B.J., STOLNIK, S., DAVIS, S.S., BIGNOTTI, F. and GARNETT, M.C., 2002. Development of multicomponent DNA delivery systems based upon poly(amidoamine)—PEG co-polymers Biochimica et Biophysica Acta: Gene Structure and Expression. 1576(3), 269-286 HEALD,C.R., STOLNIK-TRENKIC,S., KUJAWINSKI,K.S., DEMATTEIS,C., GARNETT,M.C., ILLUM,L., DAVIS,S.S., PURKISS,S.C., BARLOW,R.J. and GELLERT,P.R., 2002. Poly(lactic acid)-poly(ethylene oxide) (PLA-PEG) nanoparticles: NMR studies of the central solidlike PLA core and the liquid PEG corona Langmuir. 18(9), 3669-3675 RILEY, T., STOLNIK, S., GARNETT, M. C., ILLUM, L., DAVIS, S. S., TAYLOR, P. and TADROS, T. F., 2002. Use of Viscoelastic Measurements for Investigating Interparticle Interactions in Dispersions of Micellar-like Poly(lactic acid)-Poly(ethylene glycol) Nanoparticles Langmuir. VOL 18(PART 20), 7663-7668 DESHPANDE, MANGESH C, GARNETT, MARTIN C, VAMVAKAKI, M, BAILEY, LINDSEY, ARMES, STEVEN P and STOLNIK, SNJEZANA, 2002. Influence of polymer architecture on the structure of complexes formed by PEG-tertiary amine methacrylate copolymers and phosphorothioate oligonucleotide. Journal of Controlled Release. 81(1-2), 185-99 HEALD, C.R., STOLNIK, S., DE MATTEIS, C., GARNETT, M.C., ILLUM, L., DAVIS, S.S. and LEERMAKERS, F.A.M., 2001. Self-consistent field modelling of poly(lactic acid)-poly(ethylene glycol) particles Colloids and Surfaces A: Physicochemical and Engineering Aspects. 179(1), 79-91 GARNETT, M C, 2001. Targeted drug conjugates: principles and progress. Advanced Drug Delivery Reviews. 53(2), 171-216 RILEY,T., STOLNIK-TRENKIC,S., HEALD,C.R., XIONG,C.D., GARNETT,M.C., ILLUM,L., DAVIS,S.S., PURKISS,S.C., BARLOW,R.J. and GELLERT,P.R., 2001. Physicochemical evaluation of nanoparticles assembled from poly(lactic acid)-poly(ethylene glycol) (PLA-PEG) block copolymers as drug delivery vehicles Langmuir. 17(11), 3168-3174 STOLNIK-TRENKIC,S., DAUDALI,B., ARIEN,A., WHETSTONE,J., HEALD,C.R., GARNETT,M.C., DAVIS,S.S. and ILLUM,L., 2001. The effect of surface coverage and conformation of poly(ethylene oxide) (PEO) chains of poloxamer 407 on the biological fate of model colloidal drug carriers Biochimica et Biophysica Acta. 1514(2), 261-279 STOLNIK, S., HEALD, C. R., NEAL, J., GARNETT, M. C., DAVIS, S. S., ILLUM, L., PURKIS, S. C., BARLOW, R. J. and GELLERT, P. R., 2001. Polylactide-poly(ethylene Glycol) Micellar-like Particles as Potential Drug Carriers: Production, Colloidal Properties and Biological Performance Journal of Drug Targeting. VOL 9(PART 5), 361-378 RUNGSARDTHONG, U, DESHPANDE, M, BAILEY, L, VAMVAKAKI, M, ARMES, S P, GARNETT, M C and STOLNIK, S, 2001. Copolymers of amine methacrylate with poly(ethylene glycol) as vectors for gene therapy. Journal of Controlled Release. 73(2-3), 359-80 RACKSTRAW, B.J., MARTIN, A.L., STOLNIK, S., ROBERTS, C.J., GARNETT, M.C., DAVIES, M.C. and TENDLER, S.J.B., 2001. Microscopic investigations into PEG-cationic polymer-induced DNA condensation Langmuir. 17(11), 3185-3193 LIN, W, GARNETT, M C, DAVIS, S S, SCHACHT, E, FERRUTI, P and ILLUM, L, 2001. Preparation and characterisation of rose Bengal-loaded surface-modified albumin nanoparticles. Journal of Controlled Release. 71(1), 117-26 GARNETT, M.C., RACKSTRAW, B.J., JONES, N.A. and BIGNOTTI, F., 2001. Cationic polymer complexes and methods of making them PCT PCT/GB01/01687 04/01/2001 00:00:00
JONES, N.A., HILL, I.R.C., STOLNIK, S., BIGNOTTI, F., DAVIS, S.S. and GARNETT, M.C., 2001. Polymer chemical structure is a key determinant of physicochemical and colloidal properties of polymer-DNA complexes for gene delivery Biochimica et Biophysica Acta. 1517, 1-8 GOVENDER, T., RILEY, T., EHTEZAZI, T., GARNETT, M. C., STOLNIK, S., ILLUM, L. and DAVIS, S. S., 2000. Defining the drug incorporation properties of PLA-PEG nanoparticles International Journal of Pharmaceutics. VOL 199(NUMBER 1), 95 - 110 GARNETT, M.C., STOLNIK, S., DUNN, S.E., ARMSTRONG, I., LIN, W., SCHACHT, E., FERUTTI, P., VERT, M., DAVIES, M.C. and ILIUM, L., 1999. Application of novel biomaterials in colloidal drug delivery systems MRS Bulletin. 24(5), 49-56
GOVENDER,T., STOLNIK,S., GARNETT,M.C., ILLUM,L. and DAVIS,S.S., 1999. PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug Journal of Controlled Release. 57(2), 171-185 RILEY, T., GOVENDER, T., STOLNIK, S., XIONG, C.D., GARNETT, M.C., ILLUM, L. and DAVIS, S.S., 1999. Colloidal stability and drug incorporation aspects of micellar-like PLA-PEG nanoparticles Colloids and Surfaces B: Biointerfaces. VOL 16(NUMBER 1-4), 147 - 159 GARNETT, M C, 1999. Gene-delivery systems using cationic polymers. Critical Reviews in Therapeutic Drug Carrier Systems. 16(2), 147-207
HILL, I R, GARNETT, M C, BIGNOTTI, F and DAVIS, S S, 1999. In vitro cytotoxicity of poly(amidoamine)s: relevance to DNA delivery. Biochimica et Biophysica Acta. 1427(2), 161-74
NEAL, J. C., STOLNIK, S., SCHACHT, E., EL RAFAIE KENAWY, GARNETT, M. C., DAVIS, S. S. and ILLUM, L., 1998. In Vitro Displacement by Rat Serum of Adsorbed Radiolabeled Poloxamer and Poloxamine Copolymers from Model and Biodegradable Nanospheres Journal of Pharmaceutical Sciences. VOL 87(NUMBER 10), 1242-1248 NEAL, J C, STOLNIK, S, GARNETT, M C, DAVIS, S S and ILLUM, L, 1998. Modification of the copolymers poloxamer 407 and poloxamine 908 can affect the physical and biological properties of surface modified nanospheres. Pharmaceutical Research. 15(2), 318-24 VANDORPE, J., SCHACHT, E., DUNN, S., HAWLEY, A., STOLNIK, S., DAVIS, S.S., GARNETT, M.C., DAVIES, M.C. and ILLUM, L., 1997. Long circulating biodegradable poly(phosphazene) nanoparticles surface modified with poly(phosphazene)-poly(ethylene oxide) copolymer Biomaterials. 18(17), 1147-1152 LIN, W., GARNETT, M.C., DAVIES, M.C., BIGNOTTI, F., FERRUTI, P., DAVIS, S.S. and ILLUM, L., 1997. Preparation of surface-modified albumin nanospheres Biomaterials. 18(7), 559-566 DUNN, S.E., COOMBES, A.G.A., GARNETT, M.C., DAVIS, S.S., DAVIES, M.C. and ILLUM, L., 1997. In vitro cell interaction and in vivo biodistribution of poly(lactide-co-glycolide) nanospheres surface modified by poloxamer and poloxamine copolymers Journal of Controlled Release. 44(1), 65-76 STOLNIK, S., FELUMB, N. C., HEALD, C. R., GARNETT, M. C., ILLUM, L. and DAVIS, S. S., 1997. Adsorption behaviour and conformation of selected poly(ethylene oxide) copolymers on the surface of a model colloidal drug carrier Colloids and Surfaces A: Physicochemical and Engineering Aspects. VOL 122(NUMBER 1/3), 151-159 GOVENDER, T., STOLNIK, S., ILLUM, L., DAVIS, S. S. and GARNETT, M. C., 1997. Enhancing the incorporation of a water soluble drug into PLGA nanoparticles Journal of Pharmacy and Pharmacology. VOL 49 SUPP/4, 140
GARNETT, M.C., MACLAUGHLIN, F.C, DAVIS, S.S., BIGNOTTI, F. and FERRUTI, P., 1997. Method for attaching polyethylene glycol to macromolecules PCT PCT/GB89/01954 07/01/1997 00:00:00
SCHOENLAU, F, MAIBUECHER, A, KOEHNLEIN, W and GARNETT, M C, 1997. Mechanism of free and conjugated neocarzinostatin activity: studies on chromophore and protein uptake using a transferrin-neocarzinostatin conjugate. Zeitschrift fuer Naturforschung. C, Journal of biosciences.. 52(3-4), 245-54
GARNETT, M.C., MACLAUGHLIN, F.C, BIGNOTTI, F. and DAVIS, S.S. AND FERRUTI, P., 1996. Polyamidoamine and polyamidoamine-PEG block copolymers for DNA delivery PCT PCT/GB97/00022 01/01/1996 00:00:00
STOLNIK, S., GARNETT, M. C., DAVIES, M. C., ILLUM, L., DAVIS, S. S., BOUSTA, M. and VERT, M., 1996. Nanospheres prepared from poly(-malic acid) benzyl ester copolymers: evidence for their in vitro degradation JOURNAL OF MATERIALS SCIENCE MATERIALS IN MEDICINE. VOL 7(NUMBER 3), 161-166 HAGAN, S. A., COOMBES, A. G. A., GARNETT, M. C., DUNN, S. E., DAVIES, M. C., ILLUM, L., DAVIS, S. S., HARDING, S. E., PURKISS, S. and GELLERT, P. R., 1996. Polylactide-Poly(ethylene glycol) Copolymers as Drug Delivery Systems. 1. Characterization of Water Dispersible Micelle-Forming Systems LANGMUIR. VOL 12(NUMBER 9), 2153-2161 STOLNIK, S., GARNETT, M. C., DAVIES, M. C. and ILLUM, L., 1995. The colloidal properties of surfactant-free biodegradable nanospheres from poly(-malic acid-co-benzyl malate)s and poly(lactic acid-co-glycolide) COLLOIDS AND SURFACES A PHYSICOCHEMICAL AND ENGINEERING ASPECTS. VOL 97(NUMBER 3), 235 FITZPATRICK, J. J. and GARNETT, M. C., 1995. Studies on the mechanism of action of an MTX-HSA-MoAb conjugate ANTICANCER DRUG DESIGN. VOL 10(NUMBER 1), 11
FITZPATRICK, J. J. and GARNETT, M. C., 1995. Design, synthesis and in vitro testing of methotrexate carrier conjugates linked via oligopeptide spacers ANTICANCER DRUG DESIGN. VOL 10(NUMBER 1), 1